Application
Western blot analysis of T126A Antibody (C-term) in Y79 cell line lysates (35ug/lane). T126A (arrow) was detected using the purified Pab.Application
T126A Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the T126A Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | T126A Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TMEM126A; Transmembrane protein 126A |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TMEM126A Transmembrane protein 126A |
|---|---|
| Molecular Weight(MW) | 21527 Da |
| Tissue Specificity | Strongly expressed in brain, cerebellum, skeletal muscle, testis. High expression also found in fetal brain, fetal retinal pigmentary epithelium, and fetal retina |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential). Mitochondrion |
| Entrez Gene | 84233 |
|---|
Application
Western blot analysis of T126A Antibody (C-term) in Y79 cell line lysates (35ug/lane). T126A (arrow) was detected using the purified Pab.
Application
T126A Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the T126A Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
